News Novonesis A/S

Equities

Real-time Estimate Cboe Europe Other stock markets 05:11:02 2024-05-02 am EDT			5-day change	1st Jan Change
389.2 ^DKK	+1.46%		-0.08%	+4.61%

Apr. 30	Novozymes A/S Approves Dividend for the Last Four Months Ended December 31, 2023	CI
Apr. 08	Novozymes A/S Proposes Dividend for the Last Four Months Ended December 31, 2023	CI

Final dividend	Apr. 30	FA
Novonesis A/S : Resolutions from the annual shareholders' meeting 2024	Apr. 30	PU
Resolutions from the annual shareholders’ meeting 2024	Apr. 30	GL
Novozymes A/S Approves Dividend for the Last Four Months Ended December 31, 2023	Apr. 30	CI
Novonesis A/S : Invitation to the annual shareholders' meeting	Apr. 08	PU
Invitation to the annual shareholders’ meeting	Apr. 08	GL
Novozymes A/S Proposes Dividend for the Last Four Months Ended December 31, 2023	Apr. 08	CI
Share-based legacy RSU program granted	Apr. 08	GL
China to speed up 'new productive forces', vice president says	Mar. 26	RE
Nordic Shares Rose Thursday; Embracer Group Series B Topped Leaders	Mar. 21	DJ
Transcript : Novozymes A/S, 2024 Guidance/Update Call, Mar 21, 2024	Mar. 21
Novonensis expects 2024 adjusted EBITDA margin of 35%	Mar. 21	RE
2024 outlook and pro forma financials	Mar. 21	GL
2024 outlook and pro forma financials	Mar. 21	AQ
Novonesis Provides Earnings Guidance for the Year 2024	Mar. 21	CI
Biotalys, Novonesis Sign Deal to Advance Biofungicide Candidate Development	Mar. 18	MT
Novonesis will host a conference call regarding 2024 outlook and 2023 pro forma financials on March 21	Mar. 18	GL
Biotalys and Novonesis Announces Manufacturing and Commercialization Partnership for EVOCA NG	Mar. 18	CI
FMC Partners With Novonesis in Canada for Biosolution Products	Mar. 12	MT
Novonesis to Unveil Fit-for-Food Mood-Support Probiotic at Natural Product Expo West	Mar. 07	CI

No results for this search

NOVOZYMES : Q4 23: destocking noise offsets recovery in other key segments

February 08, 2024 at 09:18 am EST